Nuveen Asset Management’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $295K | Hold |
139,999
| – | – | ﹤0.01% | 3132 |
|
|
2024
Q3 | $377K | Hold |
139,999
| – | – | ﹤0.01% | 3096 |
|
|
2024
Q2 | $399K | Hold |
139,999
| – | – | ﹤0.01% | 3067 |
|
|
2024
Q1 | $594K | Hold |
139,999
| – | – | ﹤0.01% | 2919 |
|
|
2023
Q4 | $749K | Hold |
139,999
| – | – | ﹤0.01% | 2853 |
|
|
2023
Q3 | $602K | Hold |
139,999
| – | – | ﹤0.01% | 2781 |
|
|
2023
Q2 | $769K | Buy |
+139,999
| New | +$769K | ﹤0.01% | 2762 |
|
|
2022
Q2 | – | Sell |
-101,175
| Closed | -$600K | – | 3311 |
|
|
2022
Q1 | $600K | Buy |
101,175
+10,164
| +11% | +$60.3K | ﹤0.01% | 2958 |
|
|
2021
Q4 | $631K | Sell |
91,011
-27,445
| -23% | -$190K | ﹤0.01% | 3006 |
|
|
2021
Q3 | $907K | Sell |
118,456
-5,708
| -5% | -$43.7K | ﹤0.01% | 3020 |
|
|
2021
Q2 | $1.03M | Sell |
124,164
-50,816
| -29% | -$423K | ﹤0.01% | 2991 |
|
|
2021
Q1 | $955K | Sell |
174,980
-8,004
| -4% | -$43.7K | ﹤0.01% | 2894 |
|
|
2020
Q4 | $785K | Buy |
182,984
+1,799
| +1% | +$7.72K | ﹤0.01% | 2892 |
|
|
2020
Q3 | $545K | Buy |
181,185
+24,173
| +15% | +$72.7K | ﹤0.01% | 2928 |
|
|
2020
Q2 | $487K | Buy |
+157,012
| New | +$487K | ﹤0.01% | 2908 |
|